semaglutide step 4 versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Semaglutide for Weight Loss: A

Data suggests that adults taking the therapeutic dose of oral semaglutide can expect to lose approximately 15% to 16% of their body weight over 68 weeks

It's important to note that increased urination is not listed as a recognised side effect in the official MHRA/EMC Summaries of Product Characteristics (SmPCs) for these medications

Any significant body transformation comes from integrating other treatments and habits with semaglutide

How often to take or administer Wegovy As mentioned above, Wegovy is a weekly injection, meaning you should take it simultaneously each week

Lancet Gastroenterol Hepatol

A: Yes, Semaglutide has been shown to be safe and effective for long-term use in clinical trials